retatrutide nash trial New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats retatrutide nonalcoholic fatty liver disease

GLP-1 medications, including Mounjaro (Tirzepatide) and Semaglutide, require a medical evaluation and are not suitable for everyone

Collagen and elastin decline with age, and rapid weight changes can outpace skin recovery

Investing in quality home monitoring equipment pays dividends in health awareness and treatment optimization

Global, regional, and national prevalence of adult overweight and obesity, 19902021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021

In someone with overweight or obesity, weight loss will also lead to more regular periods. However, she says that irregular periods could signal extreme weight loss and not be a direct effect of the medication itself